Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Synergy Pharmaceuticals to Present at Upcoming September Investor Conferences
-
Aimmune Therapeutics to Participate in Three Investor Conferences in September
-
Aerie Pharmaceuticals to Present at Two Investor Conferences in September
-
Asterias Biotherapeutics to Present at Upcoming Conferences
-
Collegium to Present at Upcoming Investor Conferences
-
PDL BioPharma to Present at Two Upcoming Investor Conferences
-
TherapeuticsMD to Present at Two Upcoming Investor Conferences
-
Eagle Pharmaceuticals, Inc. to Present at September Investor Conferences
-
Egalet to Present at Investor Conferences this Fall
-
DURECT to Participate in Upcoming Healthcare Conferences
-
Allscripts to present at upcoming investor events
-
LeMaitre Vascular to Present at Upcoming Investor Conferences
-
Cytokinetics to Present at September Investor Conferences
-
ImmunoGen Announces Webcasts of Presentations at Upcoming Conferences
-
Akebia to Present at Upcoming Investor Conferences
-
ChemoCentryx to Present at Three Upcoming Investor Conferences
-
Keryx Biopharmaceuticals to Webcast its Presentations at Investor Healthcare Conferences in September 2017
-
BioSpecifics Technologies Corp. to Present at Two Upcoming September Conferences
-
Corium to Present at Upcoming Healthcare Conferences
-
Iovance Biotherapeutics to Present at Two Upcoming September Conferences
-
Tetraphase Pharmaceuticals to Present at Upcoming Investor Conferences
-
AVEO Oncology to Present at Upcoming Conferences
-
Health Insurance Innovations (HIIQ) Weakness 'Overdone' - Cantor Fitzgerald
-
Yields rise on strong U.S. manufacturing data
-
Coherus BioSciences Management to Present at Three Investor Healthcare Conferences in September
-
Amazon.com (AMZN): Updating Model For Whole Foods - Cantor Fitzgerald
-
Cantor Fitzgerald Starts MedEquities Realty Trust (MRT) at Overweight
-
The Trade Desk, Inc. (TTD): White Ops Partnership Adds Fraud Blocking - Cantor
-
Fate Therapeutics to Present at Upcoming Investor Conferences
-
Cantor Fitzgerald Downgrades CRH Medical (CRHM) to Neutral
-
Atara Biotherapeutics to Participate in Three Upcoming Investor Conferences
-
Cantor Fitzgerald Starts Global Medical REIT (GMRE) at Overweight
-
SCYNEXIS to Present at Upcoming Investor Conferences
-
OPKO Health to Present at Upcoming September Conferences
-
Amarin Corp. (AMRN): Lawsuit Defends Marketshare - Cantor
-
Mersana Therapeutics to Participate in Investor Conferences in September
-
REGENXBIO to Present at Upcoming Investor Conferences
-
Sunesis to Present at Upcoming Investor Conferences
-
Enanta Pharmaceuticals to Present at Three Upcoming Investor Conferences
-
Kamada Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
MyoKardia to Present at Two Upcoming Investor Conferences in September
-
Syndax Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences
-
Karyopharm Therapeutics to Participate in Upcoming Investor Conferences
-
Bellicum Pharmaceuticals to Present at Three Healthcare Investor Conferences in September
-
Epizyme to Participate in Upcoming Investor Conferences
-
Mesoblast (MESO): Accelerated Approval Possible In 1Q18 - Cantor Fitzgerald
-
No Fundamental Reasons for Valeant (VRX) Weakness - Cantor Fitzgerald
-
Novartis CANTOS Study for ACZ885 Bodes Well for Amarin (AMRN) - Cantor Fitzgerald
-
Advisory Board Company (ABCO) PT Raised to $54 at Cantor Fitzgerald; 'Announces Sale of Business In Two Step Process'
-
Merit Medical to Participate at Five Conferences

